USPTO Examiner CARR DEBORAH D - Art Unit 1622

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18430796COMPOSITIONS AND METHODS FOR TREATING ENDOCRINE DISEASES AND DISORDERSFebruary 2024August 2024Allow601NoNo
18403960ENHANCED CONFECTIONERYJanuary 2024August 2024Allow710YesNo
18388529Crystalline Form of Antioxidant CompoundNovember 2023May 2024Allow610YesNo
18500742PHENYLCARBAMATE CRYSTALLINE FORM AND METHOD FOR MANUFACTURING THE SAMENovember 2023April 2024Allow610NoNo
18546583PROCESS FOR SEPARATION OF METHANOL AND METHYL (METH)ACRYLATEAugust 2023December 2023Allow400NoNo
18258157Odorless Active AgentsJune 2023March 2024Allow901NoNo
18328581ACETIC ACID PRODUCTIONJune 2023August 2023Allow200NoNo
18301679METHOD FOR PREPARING GLUFOSINATE OR ANALOGUES THEREOFApril 2023September 2023Allow510NoNo
18153852METHODS OF REFINING A GRAIN OIL COMPOSITIONJanuary 2023October 2023Allow2110NoNo
18083181METHODS AND FORMULATIONS FOR ENHANCING HIGH VALUE LIPIDSDecember 2022May 2024Allow1710NoNo
18056484METHODS OF REFINING A GRAIN OIL COMPOSITIONNovember 2022December 2023Allow1310NoNo
17962984COMPOSITION CONTAINING HIGHLY UNSATURATED FATTY ACID OR ALKYL ESTER THEREOF AND A METHOD FOR PRODUCING THE SAMEOctober 2022September 2023Allow1110NoNo
17897853PROCESS AND SYSTEM FOR HEAT INTEGRATION IN ETHANOL PRODUCTIONAugust 2022March 2024Allow1910NoNo
17887416BLENDED CANNABIS COMPOUNDS AND METHODS OF MAKING THE SAMEAugust 2022January 2023Allow510NoNo
17886023LIGHT ASSISTED, CATALYST-FREE OXIDATION OF ALDEHYDES TO CARBOXYLIC ACIDS USING CARBON DIOXIDEAugust 2022April 2024Allow2000NoNo
17884959SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMSAugust 2022March 2024Allow2010NoNo
17884247METHOD AND APPARATUS FOR EXTRACTING BOTANICAL OILSAugust 2022April 2024Allow2010NoNo
17884120COMPOSITIONS AND METHODS FOR MODULATING EQUINE FATTY ACID PROFILESAugust 2022March 2024Allow1910NoNo
17759143METHOD FOR THE SIMULTANEOUS PRODUCTION OF SODIUM AND POTASSIUM ALCOHOLATESJuly 2022June 2023Allow1100NoNo
17864345COMPOSITIONS AND METHODS FOR SOLIDIFIED FERMENTED ANIMAL FEEDJuly 2022June 2023Allow1100NoNo
17846733METHODS OF PRODUCING POLYOL LIPIDSJune 2022April 2024Allow2221NoNo
17784163COMPOUND AND METHOD FOR PRODUCING THE SAME, RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICEJune 2022July 2023Allow1410YesNo
17804015Process for discharging low boilers during the production of dialkyl terephthalates or dialkyl phthalatesMay 2022March 2024Allow2200NoNo
17745773BIOENERGETICALLY ACTIVE ESTERS FOR HEALTH AND DISEASEMay 2022December 2023Allow1910NoNo
17776933CATALYSTS AND METHODS FOR GAS PHASE CARBONYLATIONMay 2022April 2024Allow2311NoNo
17663071METHODS FOR PRODUCING ALKYL HYDROXYALKANOATESMay 2022April 2024Allow2410NoNo
17700933NOVEL VEGETABLE OIL-BASED MATERIAL AS A SUBSTITUTE FOR CARNAUBA WAXMarch 2022August 2023Allow1610NoNo
17588968SALTS OF TREPROSTINILJanuary 2022November 2023Abandon2110NoNo
17649530TRANS CAROTENOIDS, THEIR SYNTHESIS, FORMULATION AND USESJanuary 2022January 2024Abandon2310NoNo
17547646OIL EXTRACTION APPARATUSDecember 2021March 2022Allow400NoNo
17529726ANTIMICROBIAL COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USING THE SAMENovember 2021March 2024Allow2810NoNo
17511419FREE-POLYUNSATURATED-FATTY-ACID-CONTAINING COMPOSITION AND METHOD FOR MANUFACTURING SAMEOctober 2021June 2024Allow3111YesNo
17498727DIFFUSION ENHANCING COMPOUNDS AND THEIR USE ALONE OR WITH THROMBOLYTICSOctober 2021May 2024Allow3110NoNo
17412797SITE-SPECIFIC ISOTOPIC LABELING OF 1,4-DIENE SYSTEMSAugust 2021May 2022Allow810NoNo
17390136PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESISJuly 2021June 2023Allow2310NoNo
17426287MONOMETHYL FUMARATE PRECURSOR DRUG COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOFJuly 2021April 2024Allow3300NoNo
17425357HIGH WATER HARD BARS COMPRISING COMBINATION OF TYPE AND AMOUNT OF ELECTROLYTESJuly 2021July 2022Allow1210NoNo
17425115AN EXTRUDED SOAP BAR WITH HIGH WATER CONTENTJuly 2021March 2022Allow800NoNo
17364280ACTION OF L-CITRULLINE TO PREVENT OR TREAT ENDOTHELIAL DYSFUNCTIONJune 2021April 2024Allow3410NoNo
17413088COMPOSITION FOR PREVENTING OR TREATING CELLULAR SENESCENCE-RELATED DISEASES COMPRISING SALINOMYCIN AS EFFECTIVE COMPONENTJune 2021July 2024Allow3710NoNo
17336615OILY MOISTURIZER AND TOPICAL SKIN COMPOSITION CONTAINING SAMEJune 2021June 2024Allow3610NoNo
17238342MODULAR, MOBILE, AND AUTOMATED SOLVENT EXTRACTION AND DISTILLATION SYSTEMS, AND METHODS OF USING THE SAMEApril 2021June 2024Allow3711NoNo
17286161ADDUCTS OF TRIPHENYLPHOSPHINE AND TRIPHENYLPHOSPHITE AND THEIR USE FOR THE BROMINATION OF PRIMARY ALCOHOLSApril 2021February 2024Allow3400NoNo
17227890COMPOUNDS AND METHODS OF MAKING STEROLS USING DIOLSApril 2021October 2023Abandon3020NoNo
17226213TRIFLUOROMETHYL ALKENYLPHOSPHONATE AND PREPARATION METHOD THEREFORApril 2021December 2023Allow3200NoNo
17283873METHOD OF MAKING CYCLOBUTANE-1, 2-DIACIDS DEGRADABLE BUILDING BLOCKS FOR MATERIALSApril 2021June 2022Allow1410YesNo
17215415INTEGRATED CAPTURE AND CONVERSION OF CO2 TO METHANE, METHANOL, OR METHANOL AND GLYCOLMarch 2021September 2022Allow1700NoNo
17280235BIOENERGETICALLY ACTIVE ESTERS FOR HEALTH AND DISEASEMarch 2021January 2022Allow1000NoNo
17278994USE OF GEMFIBROZIL AND DERIVATIVE THEREOF FOR TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASEMarch 2021May 2024Allow3710NoNo
17207380TREATMENT OF SICKLE CELL DISEASE USING THERAPEUTICALLY EFFECTIVE ORAL DOSES OF 10-NITRO-9(E)-OCTADEC-9-ENOIC ACIDMarch 2021June 2024Abandon3910NoNo
17278170PHARMACEUTICAL COMPOSITIONMarch 2021October 2023Allow3100NoNo
17206397Infusing Raw Cannabinoids Into Food OilMarch 2021June 2024Allow3910NoNo
17276800DERMATOLOGIC TOPICAL APPLICATIONS OF ROR GAMMA AND ROR GAMMA-T INHIBITORS FOR THE PREVENTION OF SKIN CANCER DEVELOPMENTMarch 2021May 2024Allow3810NoNo
17274883Novel Treprostinil SaltMarch 2021June 2024Allow3910NoNo
17274779Application of p-Hydroxyphenylpropionic Acid to Prepare Medicine for Preventing and Treating Respiratory Tract InfectionMarch 2021June 2024Abandon3910NoNo
17186538Synthesis of the Organoarsenical Antibiotic Arsinothricin and Derivatives ThereofFebruary 2021May 2022Allow1510NoNo
17270505METHOD FOR STABILIZING SANSHOOL COMPOUNDFebruary 2021September 2023Allow3100NoNo
17270760MONOGLYCERIDE USE IN ANIMALSFebruary 2021April 2024Allow3810NoNo
17268225Cosmetic CompositionsFebruary 2021September 2023Allow3100NoNo
17268203METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERSFebruary 2021February 2024Allow3610NoNo
17265058ELAFIBRANOR SALTSFebruary 2021April 2024Allow3810NoNo
17264924A NEW MEDICAL TREATMENT FOR PATHOLOGIC INFLAMMATIONFebruary 2021September 2023Allow3200NoNo
17264477METHODS FOR TREATING NEURODEGENERATIVE DISORDERSJanuary 2021April 2024Allow3920YesNo
17154646COMPOSITION CONTAINING HIGHLY UNSATURATED FATTY ACID OR ALKYL ESTER THEREOF AND A METHOD FOR PRODUCING THE SAMEJanuary 2021July 2022Allow1710NoNo
17150898LIPID COMPRISING POLYUNSATURATED FATTY ACIDSJanuary 2021July 2023Allow3010NoNo
17258090Methods and Compositions for Treating Pain and ItchJanuary 2021May 2024Abandon4010NoNo
17141058METHOD AND APPARATUS FOR EXTRACTING BOTANICAL OILSJanuary 2021March 2022Allow1500NoNo
17141119PROCESS FOR GENERATING HEMP OIL WITH A HIGH CANNABIDIOL (CBD) CONTENTJanuary 2021December 2022Abandon2310NoNo
16973852COMPOSITION FOR TREATMENT OF DRY EYE DISEASE AND MEIBOMIANITISDecember 2020February 2024Allow3810NoNo
17112891METHOD FOR PREPARING PREGABALIN INTERMEDIATE (R)-3-(CARBAMOYLMETHYL)-5-METHYLHEXANOIC ACIDDecember 2020May 2022Allow1710NoNo
17110567COMPOUNDS AND METHODS FOR TREATING INFLUENZADecember 2020April 2022Allow1610NoNo
17107643SALTS OF TREPROSTINILNovember 2020September 2021Allow1000NoNo
17058932METHOD FOR PRODUCING POLYHYDROXYALKANOATENovember 2020January 2022Allow1400NoNo
17097221DOCOSAHEXAENOIC ACID-CONTAINING OIL AND METHOD FOR PRODUCING SAMENovember 2020August 2022Allow2120NoNo
17055083METHOD OF ISOLATING LIPIDS FROM A LYSED LIPIDS CONTAINING BIOMASS BY EMULSION INVERSIONNovember 2020January 2024Allow3810NoNo
17052907PROCESS FOR ENZYMATIC OIL DEGUMMINGNovember 2020September 2023Allow3410NoNo
17079935VEGETABLE OIL-BASED MATERIAL AS A SUBSTITUTE FOR CARNAUBA WAXOctober 2020December 2021Allow1400NoNo
17048286COMPOSITIONS FOR ATTRACTING PESTS AND USES THEREOFOctober 2020May 2024Abandon4310NoNo
17063009METHODS OF REFINING A GRAIN OIL COMPOSITION, AND RELATED COMPOSITIONS AND METHODS OF USINGOctober 2020April 2024Allow4210NoNo
17026771METHODS OF REFINING A GRAIN OIL COMPOSITIONSeptember 2020August 2022Allow2310NoNo
17026224METHOD OF PREPARING HYDROXYTYROSOL CINNAMIC ACID ESTER WITH ANTIOXIDANT AND ANTIBACTERIAL ACTIVITIESSeptember 2020July 2022Allow2210NoNo
17008640PROCESS FOR PRODUCING 1,3-BUTANEDIOL AND FOR OPTIONALLY FURTHER PRODUCING (R)-3-HYDROXYBUTYL (R)-3-HYDROXYBUTYRATESeptember 2020March 2021Allow710NoNo
16995338CONVERSION OF DICARBOXYLIC ACIDS TO MONOMERS AND PLASTICIZERSAugust 2020April 2022Allow2000NoNo
16983460PROCESS AND SYSTEM FOR HEAT INTEGRATION IN ETHANOL PRODUCTIONAugust 2020April 2022Allow2111NoNo
16928649INTEGRATED CAPTURE AND CONVERSION OF CO2 TO METHANOL OR METHANOL AND GLYCOLJuly 2020November 2020Allow400NoNo
16961740FLEXIBLE WAX AND METHOD OF MAKING SAMEJuly 2020February 2023Allow3110YesNo
16923804RADICAL INITIATORS AND CHAIN EXTENDERS FOR CONVERTING METHANE GAS INTO METHANE-SULFONIC ACIDJuly 2020March 2022Allow2000NoNo
16918187Process for the Decarboxylation, Isomerization, Hydrogenation, Dehydrogenation and Cyclization Aromatization of Fatty Acids Yielding Products with Significant Aromatic ContentJuly 2020August 2021Allow1300NoNo
16916448Method for Preparing Functional Grease through Segmented Solid-State Fermentation of Mixed FungiJune 2020August 2023Allow3800NoNo
16958885PURIFICATION OF BIOMASS-BASED LIPID MATERIALJune 2020March 2021Allow910NoNo
16914224METHOD AND PRODUCTION SYSTEM FOR FULLY RECOVERING AND TREATING TAURINE MOTHER LIQUORJune 2020November 2020Allow510NoNo
16957618Oil and Fat Composition, Use Thereof and Food Comprising The SameJune 2020November 2022Allow2910NoNo
16956820OIL COMPRISING AT LEAST ONE POLYUNSATURATED FATTY ACID HAVING AT LEAST 20 CARBON ATOMS (LC-PUFA)June 2020January 2023Allow3110NoNo
16956977HARDSTOCK FAT COMPOSITIONJune 2020August 2022Allow2610NoNo
16956252METHOD OF REMOVING NITRATE COMPOUNDS FROM ADIPIC ACIDJune 2020February 2021Allow810NoNo
16954551PROCESS FOR PREPARING A POWDERY ORGANIC PEROXIDE FORMULATIONJune 2020April 2021Allow1010NoNo
16900270Mobile Crop Processing System and MethodJune 2020March 2022Abandon2101NoNo
16899168METHOD OF PRODUCING LIQUID SOAP FROM SOLID SOAP CONCENTRATEJune 2020August 2022Allow2600NoNo
16895763ENZYMATIC DEGUMMING OF UNREFINED TRIGLYCERIDE OILJune 2020July 2022Allow2510NoNo
16893890SYNTHESIS OF THE ORGANOARSENICAL ANTIBIOTIC ARSINOTHRICIN AND DERIVATIVES THEREOFJune 2020November 2020Allow600NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CARR, DEBORAH D.

Strategic Value of Filing an Appeal

Total Appeal Filings
5
Allowed After Appeal Filing
1
(20.0%)
Not Allowed After Appeal Filing
4
(80.0%)
Filing Benefit Percentile
21.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner CARR, DEBORAH D - Prosecution Strategy Guide

Executive Summary

Examiner CARR, DEBORAH D works in Art Unit 1622 and has examined 406 patent applications in our dataset. With an allowance rate of 84.7%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 19 months.

Allowance Patterns

Examiner CARR, DEBORAH D's allowance rate of 84.7% places them in the 55% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by CARR, DEBORAH D receive 1.09 office actions before reaching final disposition. This places the examiner in the 16% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by CARR, DEBORAH D is 19 months. This places the examiner in the 91% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -0.5% benefit to allowance rate for applications examined by CARR, DEBORAH D. This interview benefit is in the 9% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 36.3% of applications are subsequently allowed. This success rate is in the 78% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 71.4% of cases where such amendments are filed. This entry rate is in the 91% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 63.6% are granted (fully or in part). This grant rate is in the 80% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.0% of allowed cases (in the 68% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.1% of allowed cases (in the 76% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.